Robert Zeillinger
Overview
Explore the profile of Robert Zeillinger including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
188
Citations
3490
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Genetic Variants of Interleukin-8 and Interleukin-16 and Their Association with Cervical Cancer Risk
Watrowski R, Schuster E, Polterauer S, Van Gorp T, Hofstetter G, Fischer M, et al.
Life (Basel)
. 2025 Feb;
15(2).
PMID: 40003544
Background: Cervical cancer (CC) is the fourth most common cancer diagnosis in women worldwide. Infection with high-risk human papillomavirus (HPV) is a critical but not determinative condition for CC development,...
2.
Watrowski R, Schuster E, Van Gorp T, Hofstetter G, Fischer M, Mahner S, et al.
Int J Mol Sci
. 2024 Oct;
25(19).
PMID: 39408600
Single nucleotide polymorphisms (SNPs) of the IL-16 gene have been reported to influence the risk of several cancers, but their role in ovarian cancer (OC) has not been studied. Using...
3.
Welsch E, Bonstingl L, Holzer B, Schuster E, Weiss E, Zaharie A, et al.
Clin Exp Metastasis
. 2024 Sep;
41(6):937-945.
PMID: 39305397
Circulating tumor cells (CTCs) are an established prognostic marker in metastatic prostate cancer (PrC) but have received little attention in localized high-risk disease. Peripheral blood was obtained from patients with...
4.
Arends C, Kopp K, Hablesreiter R, Estrada N, Christen F, Moll U, et al.
Leukemia
. 2024 May;
38(6):1440.
PMID: 38714878
No abstract available.
5.
Fromhage G, Obermayr E, Bednarz-Knoll N, Van Gorp T, Welsch E, Polterauer S, et al.
Int J Cancer
. 2024 May;
155(5):934-945.
PMID: 38709956
We analyzed variations in the epidermal growth factor receptor (EGFR) gene and 5'-upstream region to identify potential molecular predictors of treatment response in primary epithelial ovarian cancer. Tumor tissues collected...
6.
Obermayr E, Mohr T, Schuster E, Braicu E, Taube E, Sehouli J, et al.
Int J Cancer
. 2024 Apr;
155(6):1128-1138.
PMID: 38676430
Disease progression is a major problem in ovarian cancer. There are very few treatment options for patients with platinum-resistant ovarian cancer (PROC), and therefore, these patients have a particularly poor...
7.
Arends C, Kopp K, Hablesreiter R, Estrada N, Christen F, Moll U, et al.
Leukemia
. 2024 Apr;
38(6):1378-1389.
PMID: 38637689
Clonal hematopoiesis (CH) driven by mutations in the DNA damage response (DDR) pathway is frequent in patients with cancer and is associated with a higher risk of therapy-related myeloid neoplasms...
8.
Watrowski R, Schuster E, Hofstetter G, Fischer M, Mahner S, Van Gorp T, et al.
Biomedicines
. 2024 Feb;
12(2).
PMID: 38397923
Interleukin-8 (IL-8) is involved in the regulation of inflammatory processes and carcinogenesis. Single-nucleotide polymorphisms (SNPs) within the IL-8 gene have been shown to alter the risks of lung, gastric, or...
9.
Welsch E, Holzer B, Schuster E, Fabikan H, Weinlinger C, Hauptmann-Repitz E, et al.
Int J Cancer
. 2024 Feb;
154(12):2189-2199.
PMID: 38353516
Small-cell lung cancer (SCLC) is a fatal disease with limited treatment options. Circulating tumor cells (CTCs) in liquid biopsy samples may serve as predictive and prognostic biomarkers; but the analysis...
10.
Heinzl N, Maritschnegg E, Koziel K, Schilhart-Wallisch C, Heinze G, Yang W, et al.
Oncogene
. 2023 Jul;
42(33):2473-2484.
PMID: 37402882
TP53 is the most commonly mutated gene in cancer and has been shown to form amyloid-like aggregates, similar to key proteins in neurodegenerative diseases. Nonetheless, the clinical implications of p53...